Europe's second-largest economy is in turmoil: on Monday, French Prime Minister Sébastien Lecornu resigned after just one month in office. President Emmanuel Macron has now tasked the Prime Minister with finding a way out of the political crisis after all. Negotiations are set to continue until Wednesday evening.
With Lecornu, Macron would be losing the third prime minister. Since the snap elections in summer 2024, the French parliament has been extremely fragmented, making it difficult to form a stable government.
To overcome the deadlock, the call for new elections is once again growing. However, it is questionable whether this would shift the allocation of seats enough to make it easier to form a majority.
The French stock market reacted to the news from the Élysée Palace with losses. The leading index, the Cac 40, fell by around 1.3% on Monday. But even prior to the latest political escalation, the French stock market has underperformed compared to other European stock exchanges over the course of the year. The Cac 40 has gained 14.4% since the beginning of the year (as of 3 October 2025, including dividends), lagging behind the stock markets in Frankfurt (Dax: +22.5%), Milan (FTSE Mib: +31.7%) and Madrid (Ibex: +37.9%).
For investors who believe that French equities will see moderate price gains, but who do not want to take the risk of a direct investment, a barrier reverse convertible could be an option. With Axa, LVMH, Saint-Gobain and Sanofi, the current subscription product combines four major players from four different sectors (finance, consumer cyclicals, industrials and healthcare). All stocks are rated 'overweight' by the research of Zürcher Kantonalbank.
Barrier Reverse Convertibles on French Equities
qCHF
11.10% p.a. BRC auf Axa, LVMH, Saint-Gobain, Sanofi
Barrier: 65.50%
Valor: 149 281 086
EUR
12.65% p.a. BRC on Axa, LVMH, Saint-Gobain, Sanofi
Barrier: 65%
Valor: 149 281 084
Indicative terms
Disclaimer
This communication is for marketing purposes. It is neither an offer nor an invitation to submit an offer, to purchase or to subscribe to securities and does not constitute investment advice. You should consult your advisors before making an investment decision. Forward-looking statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, financial condition, development or performance of the issuer to be materially different from any future results, financial condition, development or performance expressed or implied by such statements. The present document has not been drawn up by the research department as defined in the rules of the “Directives on the Independence of Financial Research” published by the Swiss Bankers Association, hence these rules do not apply to this document. If securities are mentioned in the communication, the base prospectus, the final terms and any key information document may be obtained free of charge from Zürcher Kantonalbank, Bahnhofstrasse 9, 8001 Zurich, VRIS, and from www.zkb.ch/finanzinformationen.
© 2025 Zürcher Kantonalbank. All rights reserved.
ZKB Autocallable Barrier Reverse Convertible on worst of Comet Holding AG/INFICON HOLDING AG/VAT Gro... 134141435 / CH1341414352 |
ZKB Autocallable Barrier Reverse Convertible on worst of Baloise-Holding AG/Swiss Life Holding AG/Zu... 134141312 / CH1341413123 |
ZKB Tracker Zertifikat Nikkei 225 Index 1321155 / CH0013211559 |
ZKB Tracker-Zertifikat Dynamisch auf Freigeist Cannabis Opportunity AMC 113976239 / CH1139762392 |
ZKB Barrier Reverse Convertible on worst of Walmart Inc/Costco Wholesale Corp/Target Corp 140250696 / CH1402506963 |